Clinical trials
Active, not recruiting Phase 1/2 trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| GlaxoSmithKline | 4 |
| Genmab | 3 |
| Novartis Pharmaceuticals | 3 |
| Celgene | 2 |
| Denali Therapeutics Inc. | 2 |
| Janssen Research & Development, LLC | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neoplasm Metastasis | 5 |
| Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Multiple Myeloma | 4 |
| Recurrence | 3 |
| Stomach Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Transitional Cell | 2 |
| Genetic Diseases, Inborn | 2 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.